A new, fully validated and interpreted quantitative structure-activity relationship model of p-aminosalicylic acid derivatives as neuraminidase inhibitors

Chemical Papers

Volumn 67, Issue 5, 2013, Pages 556-567

  Hartmman, Ana Paula ^a   Jornada, Daniela Hartmman ^a   De Melo, Eduardo Borges ^a  

^a Theoretical Medicinal and Environmental Chemistry Laboratory (LQMAT) Department of Pharmacy   (Brazil)

Author keywords

H1N1; mechanistic interpretation; model validation; OPS; PLS; QSAR

Indexed keywords

EID: 84879695897     PISSN: 03666352     EISSN: 13369075     Source Type: Journal    
DOI: 10.2478/s11696-013-0321-0     Document Type: Article

References (61)

1. Abed, Y., Baz, M., & Boivin, G. (2009). A novel neuraminidase deletion mutation conferring resistance to oseltamivir in clinical influenza A/H3N2 virus. The Journal of Infectious Disease, 199, 180-183. DOI: 10.1086/595736.
2. Accelrys (2009). Discovery Studio Visualizer 2.5.5 [computer software]. San Diego, CA, USA: Accelrys, Inc.
3. ACD/Labs (2010). ACD/ChemSketch 12 [computer software]. Toronto, Canada: Advanced Chemistry Development, Inc.
4. 2 for the training set or low root mean square error of prediction for the test set? QSAR & Combinatorial Science, 24, 385-396. DOI: 10.1002/qsar.200430909.
5. Brazilian Health Surveillance Secretariat (2009). Situação epidemiológica da Influenza Pandȩmica (H1N1) 2009 no Mundo e no Brasil, até a Semana Epidemiológica 47 de 2009. Retrieved November 20, 2012, from http://portal.saude.gov.br/portal/arquivos/pdf/boletim- influenza-se-47.pdf
6. Consonni, V., Todeschini, R., & Pavan, M. (2002). Structure/response correlations and similarity/diversity analysis by GETAWAY descriptors. 1. Theory of the novel 3D molecular descriptors. Journal of Chemical Information and Computer Science, 42, 682-692. DOI: 10.1021/ci015504a.
7. Dave, K., Gandhi, M., Panchal, H., & Vaidya, M. (2011). Revision of QSAR, docking, and molecular modeling studies of anti-influenza virus A (H1N1) drugs and targets: Analysis of hemagglutinins 3D structure. Current Computer-Aided Drug Design, 7, 255-262.
8. de Fátima, A., Baptistella, L. H. B., Pilli, R. A., & Modolo, L. V. (2005). Sialic acids: from the comprehension of their involvement in biological processes to antiinfluenza drug design. Química Nova, 28, 306-316. DOI: 10.1590/s0100-40422005000200023.
9. de Melo, E. B. (2012). A new quantitative structure-property relationship model to predict bioconcentration factors of polychlorinated biphenyls (PCBs) in fishes using E-state index and topological descriptors. Ecotoxicological and Environmental Safety, 75, 213-222. DOI: 10.1016/j.ecoenv.2011.08.026.
10. de Melo, E. B., & Ferreira, M. M. C. (2009). Multivariate QSAR study of 4,5-dihydroxypyrimidine carboxamides as HIV-1 integrase inhibitors. European Journal of Medicinal Chemistry, 44, 3577-3583. DOI: 10.1016/j.ejmech.2009.03. 001.
11. Ekiert, D. C., Bhabha, G., Elsliger, M. A., Friesen, R. H. E., Jongeneelen, M., Throsby, M., Goudsmit, J., & Wilson, I. A. (2009). Antibody recognition of a highly conserved influenza virus epitope. Science, 324, 246-251. DOI: 10.1126/science.1171491.
12. Ekiert, D. C., Friesen, R. H. E., Bhabha, G., Kwaks, T., Jongeneelen, M., Yu, W. L., Ophorst, C., Cox, F., Korse, H. J. W. M., Brandenburg, B., Vogels, R., Brakenhoff, J. P. J., Kompier, R., Koldijk, M. H., Cornelissen, L. A. H. M., Poon, L. L. M., Peiris, M., Koudstaal, W., Wilson, I. A., & Goudsmit, J. (2011). A highly conserved neutralizing epitope on group 2 influenza A viruses. Science, 333, 843-850. DOI: 10.1126/science.1204839.
13. Eriksson, L., Jaworska, J., Worth, A. P., Cronin, M. T. D., McDowell, R. M., & Gramatica, P. (2003). Methods for reliability and uncertainty assessment and for applicability evaluations of classification and regression-based QSARs. Environmental Health Perspectives, 111, 1361-1375. DOI: 10.1289/ehp.5758.
14. Falagas, M. E., Koletsi, P. K., Vouloumanou, E. K., Rafailidis, P. I., Kapaskelis, A. M., & Rello, J. (2010). Effectiveness and safety of neuraminidase inhibitors in reducing influenza complications: a meta-analysis of randomized controlled trials. Journal of Antimicrobial Chemotherapy, 65, 1330-1346. DOI: 10.1093/jac/dkq158.
15. Ferreira, M. M. C. (2002). Multivariate QSAR. Journal of the Brazilian Chemical Society, 13, 742-753. DOI: 10.1590/s0103-50532002000600004.
16. Gaudio, A. C., & Zandonade, E. (2001). Proposition, validation and analysis of QSAR models. Quimica Nova, 24, 658-671. DOI: 10.1590/s0100- 40422001000500013.
17. 2! Journal of Molecular Graphics and Modelling, 20, 269-276. DOI: 10.1016/s1093-3263(01)00123-1.
18. Golbraikh, A., Shen, M., Xiao, Z., Xiao, Y. D., Lee, K. H. & Tropsha, A. (2003). Rational selection of training and test set for the development of validated QSAR models. Journal of Computer-Aided Molecular Design, 17, 241-253. DOI: 10.1023/a:1025386326946.
19. 2A adenosine receptors agonists. European Journal of Medicinal Chemistry, 40, 1080-1086. DOI: 10.1016/j.ejmech.2005.04.014.
20. Gramatica, P. (2007). Principles of QSAR models validation: internal and external. QSAR & Combinatorial Science, 26, 694-701. DOI: 10.1002/qsar.200610151.
21. Gupta, R. A., Gupta, A. K., Soni, L. K., & Kaskhedikar, S. G. (2009). Study of physicochemical properties-antitubercular activity relationship of naphthalene-1,4-dione analogs: A QSAR approach. Chemical Papers, 63, 723-730. DOI: 10.2478/s11696-009-0080-0.
22. Hernández, N., Kiralj, R., Ferreira, M. M. C., & Talavera, I. (2009). Critical comparative analysis, validation and interpretation of SVM and PLS regression models in a QSAR study on HIV-1 protease inhibitors. Chemometrics and Intelligent Laboratory Systems, 98, 65-77. DOI: 10.1016/j.chemolab.2009.04. 012.
23. Horimoto, T., & Kawaoka, T. (2001). Pandemic threat posed by avian influenza A viruses. Clinical Microbiology Reviews, 14, 129-149. DOI: 10.1128/cmr.14.1.129-149.2001.
24. HyperCube (2002). HyperChem 7.0 [computer software]. Gainesville, FL, USA: HyperCube, Inc.
25. Infometrix (2007). Pirouette 4 [computer software]. Bothell, WA, USA: Infometrix, Inc.
26. Karelson, M., Lobanov, V. S., & Katritzky, A. R. (1996). Quantum-chemical descriptors in QSAR/QSPR studies. Chemical Reviews, 96, 1027-1043. DOI: 10.1021/cr950202r.
27. Katritzky, A. R., Petrukhin, R., Tatham, D., Basak, S., Benfenati, E., Karelson, M., & Maran, U. (2001). Interpretation of quantitative structure-property and -activity relationships. Journal of Chemical Information and Computer Science, 41, 679-685. DOI: 10.1021/ci000134w.
28. Kiralj, R., & Ferreira, M. M. C. (2009). Basic validation procedures for regression models in QSAR and QSPR studies: theory and application. Journal of Brazilian Chemical Society, 20, 770-787. DOI: 10.1590/s0103- 50532009000400021.
29. Liu, P. X., & Long, W. (2009). Current mathematical methods used in QSAR/QSPR studies. International Journal of Molecular Science, 10, 1978-1998. DOI: 10.3390/ijms10051978.
30. Luan, F., Melo, A., Borges, F., & Cordeiro, M. N. D. S. (2011). Affinity prediction on A3 adenosine receptor antagonists: the chemometric approach. Bioorganic & Medicinal Chemistry, 19, 6853-6859. DOI: 10.1016/j.bmc.2011.09.032.
31. Marshall, S. J. (2005). Governments in a dilemma over bird flu. Retrieved November 20, 2012, from http://www.who.int/bulletin/volumes/83/5/infocus0505/en
32. Martins, J. P. A., & Ferreira, M. M. C. (2010). QSAR modeling [computer software]. Campinas, SP, Brazil: Unicamp.
33. Masoodi, T. A., Shaik, N. A., Shafi, G., Munshi, A., Ahamed, A. K., & Masoodi, Z. A. (2012). Comparative analysis of hemagglutinin of 2009 H1N1 influenza A pandemic indicates its evolution to 1918 H1N1 pandemic. Gene, 491, 200-204. DOI: 10.1016/j.gene.2011.09.024.
34. Melagraki, G., Afantitis, A., Sarimveis, H., Koutentis, P. A., Markopolus, J., & Igglessi-Markopoulou, O. (2007). Optimization of biaryl piperidine and 4-amino-2-biarylurea MCH1 receptor antagonists using QSAR modeling, classification techniques and virtual screening. Journal of Computer-Aided Molecular Design, 21, 251-267. DOI: 10.1007/s10822-007-9112-4.
35. Molfetta, F. A., Bruni, A. T., Rosseli, F. P., & da Silva, A. B. F. (2007). A partial least squares and principal component regression study of quinone compounds with trypanocidal activity. Structural Chemistry, 18, 49-57. DOI: 10.1007/s11224-006-9120-3.
36. OECD (2007). Guidance document on the validation of (quantitative) structure-activity relationships [(Q)SAR] models. Retrieved November 20, 2012, from http://search.oecd.org/officialdocuments/displaydocumentpdf/?doclanguage= en&cote=env/jm/mono(2007)2
37. 2 metrics for validation of QSPR models. Chemometrics and Intelligent Laboratory Systems, 107, 194-205. DOI: 10.1016/j.chemolab.2011.03.011.
38. Put, R., Xu, Q. S., Massart, D. L., & Heyden, Y. V. (2004). Multivariate adaptive regression splines (MARS) in chromatographic quantitative structure-retention relationship studies. Journal of Chromatography A, 1055, 11-19. DOI: 10.1016/j.chroma.2004.07.112.
39. Ribeiro, F. A., & Ferreira, M. M. C. (2003). QSPR models of boiling point, octanol-water partition coefficient and retention time index of polycyclic aromatic hydrocarbons. Journal of Molecular Structure: THEOCHEM, 663, 109-126. DOI: 10.1016/j.theochem.2003.08.107.
40. Rizzo, C., Ajelli, M., Merler, S., Pugliese, A., Barbetta, I., Salmaso, S., & Manfredi, P. (2011). Epidemiology and transmission dynamics of the 1918-19 pandemic influenza in Florence, Italy. Vaccine, 29(S2), B27-B32. DOI: 10.1016/j.vaccine.2011.02.049.
41. Roy, P. P., Paul, S., Mitra, I., & Roy, K. (2009). On two novel parameters for validation of predictive QSAR models. Molecules, 14, 1660-1701. DOI: 10.3390/molecules15010604.
42. Sharma, B. K., Singh, P., Pilania, P., Sarbhai, K., & Prabhakar, Y. S. (2011). CP-MLR/PLS directed QSAR study on apical sodium-codependent bile acid transporter inhibition activity of benzothiepines. Molecular Diversity, 15, 135-147. DOI: 10.1007/s11030-009-9220-2.
43. Silla, J. M., Nunes, C. A., Cormanich, R. A., Guerreiro, M. C., Ramalho, T. C., & Freitas, M. P. (2011). MIA-QSPR and effect of variable selection on the modeling of kinetic parameters related to activities of modified peptides against dengue type 2. Chemometrics and Intelligent Laboratory Systens, 108, 146-149. DOI: 10.1016/j.chemolab.2011.06.009.
44. Silva, P. (2010). Farmacologia (8th ed.). Rio de Janeiro, RJ, Brazil: Guanabara Koogan.
45. Stanton, D. T. (2003). On the physical interpretation of QSAR models. Journal of Chemical Information and Computer Science, 43, 1423-1433. DOI: 10.1021/ci0340658.
46. Teófilo, R. F., Martins, J. P. A., & Ferreira, M. M. C. (2009). Sorting variables by using informative vectors as a strategy for feature selection in multivariate regression. Journal of Chemometrics, 23, 32-48. DOI: 10.1002/cem.1192.
47. Tetko, I. V., Gasteiger, J., Todeschini, R., Mauri, A., Livingstone, D., Ertl, P., Palyulin, V. A., Radchenko, E. V., Zefirov, N. S., Makarenko, A. S., Tanchuk, V. Y., & Prokopenko, V. V. (2005). Virtual computational chemistry laboratory - design and description. Journal of Computer-Aided Molecular Design, 19, 453-463. DOI: 10.1007/s10822-005-8694-y.
48. Todeschini, R., Consonni, V., Mauri, A., & Pavan, M. (2003). Dragon Web Version 3.0 [computer software]. Milano, Italia: Talete, Srl.
49. Todeschini, R. C., & Consonni, V. (2009). Molecular descriptors for chemoinformatics (2th ed.). Weinheim, Germany: Wiley-VCH.
50. Trilla, A., Trilla, G., & Daer, C. (2005). The 1918 "Spanish flu" in Spain. Clinical Infectious Disease, 47, 668-673. DOI: 10.1086/590567.
51. Wanderley, M. R., Sampaio, G. P., de Negreiros, M. A. M. P., & Casseb, G. B. (2011). Epidemiologial description of Influenza H1N1 cases in terciary medical service Rio Branco's Urgency and Emergency Hospital. Revista da Sociedade Brasileira de Clínica Médica, 9, 279-282.
52. Weininger, D. (1988). SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules. Journal of Chemical Information and Computer Science, 28, 31-36. DOI: 10.1021/ci00057a005.
53. Wilson, J. M., Iannarone, M., & Wang, C. (2009). Media reporting of the emergence of the 1968 influenza pandemic in Hong Kong: Implications for modern-day situational awareness. Disaster Medicine and Public Health Preparedness, 3, S148-S153.
54. Wold, S. (1995). PLS for multivariate linear modeling. In H. van de Waterbeemd (Ed.), Chemometric methods in molecular design (pp. 195-218). Weinheim, Germany: Wiley-VCH. DOI: 10.1002/9783527615452.
55. Wold, S., & Eriksson, L. (1995). Validation tools. In H. van de Waterbeemd (Ed.), Chemometric methods in molecular design (pp. 309-318). Weinheim, Germany: Wiley-VCH. DOI: 10.1002/9783527615452.
56. Wold, S., Sjöström, M., & Eriksson, L. (2001). PLS-regression: a basic tool of chemometrics. Chemometrics and Intelligent Laboratory Systems, 58, 109-130. DOI: 10.1016/s0169-7439(01)00155-1.
57. World Health Organization (2009a). Pandemic (H1N1) 2009 - update 80. Retrieved November 20, 2012, from: http://www.who.int/csr/don/20091223/en
58. World Health Organization (2009b). WHO recommendations on pandemic (H1N1) 2009 vaccines. Retrieved November 20, 2012, from http://www.who.int/csr/ disease/swineflu/notes/h1n1vaccine20090713/en/index.html
59. World Health Organization (2011). Standardization of terminology of the pandemic A(H1N1)2009 virus. Retrieved November 20, 2012, from http://www.who.int/influenza/gisrslaboratory/terminology-ah1n1pdm09/en/index. html
60. Xu, X. J., Zhu, X. Y., Dwek, R. A., Stevens, J., & Wilson, I. A. (2008). Structural characterization of the 1918 influenza virus H1N1 neuraminidase. Journal of Virology, 82, 10493-10501. DOI: 10.1128/jvi.00959-08.
61. Zhang, J., Wang, Q., Fang, H., Xu, W. F., Liu, A., & Du, G. H. (2008). Design, synthesis, inhibitory activity, and SAR studies of hydrophobic p-aminosalicylic acid derivatives as neuraminidase inhibitors. Bioorganic & Medicinal Chemistry, 16, 3839-3847. DOI: 10.1016/j.bmc.2008.01.036.